Search results for "K-Bio"

Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors

Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors

When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the anomaly drives the condition or...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties

Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties

Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are raising expectations that...
Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Major institutional asset managers are steadily increasing their equity stakes in South Korean pharmaceutical and...
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's...
KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation

KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation

Staff supporting biohealth research and development (R&D) spend substantial time navigating and analyzing massive...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2

South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway

South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway

"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are...
South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy

South Korea Overhauls Pharma and Biotech Disclosure Rules Following Samchundang Controversy

South Korean financial authorities are overhauling disclosure regulations across the pharmaceutical and biotechnology...
117 Workplace Accidents Recognized at 25 Major Korean Pharma and Biotech Firms Over Five Years

117 Workplace Accidents Recognized at 25 Major Korean Pharma and Biotech Firms Over Five Years

A review of 25 major South Korean pharmaceutical and biotechnology companies revealed 117 recognized industrial...
Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Biogen Korea has appointed Kim Chul-woong as its new general manager, tapping an executive with extensive expertise in...